248 related articles for article (PubMed ID: 23194247)
1. Bisphosphonate-anchored PEGylation and radiolabeling of superparamagnetic iron oxide: long-circulating nanoparticles for in vivo multimodal (T1 MRI-SPECT) imaging.
Sandiford L; Phinikaridou A; Protti A; Meszaros LK; Cui X; Yan Y; Frodsham G; Williamson PA; Gaddum N; Botnar RM; Blower PJ; Green MA; de Rosales RT
ACS Nano; 2013 Jan; 7(1):500-12. PubMed ID: 23194247
[TBL] [Abstract][Full Text] [Related]
2. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
[TBL] [Abstract][Full Text] [Related]
3. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
[TBL] [Abstract][Full Text] [Related]
4. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
5. (⁹⁹m)Tc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging.
Torres Martin de Rosales R; Tavaré R; Glaria A; Varma G; Protti A; Blower PJ
Bioconjug Chem; 2011 Mar; 22(3):455-65. PubMed ID: 21338098
[TBL] [Abstract][Full Text] [Related]
6. Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles.
Pham TN; Lengkeek NA; Greguric I; Kim BJ; Pellegrini PA; Bickley SA; Tanudji MR; Jones SK; Hawkett BS; Pham BT
Int J Nanomedicine; 2017; 12():899-909. PubMed ID: 28184160
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vivo evaluation of PEG-BP-BaYbF
Imberti C; Fedatto Abelha T; Yan Y; Lange J; Cui X; Szanda I; Goh V; Dailey LA; T M de Rosales R
J Mater Chem B; 2020 Sep; 8(34):7723-7732. PubMed ID: 32725026
[TBL] [Abstract][Full Text] [Related]
8. Ultrasmall superparamagnetic iron oxide nanoparticles for magnetic resonance imaging contrast agent.
Zhao X; Zhao H; Chen Z; Lan M
J Nanosci Nanotechnol; 2014 Jan; 14(1):210-20. PubMed ID: 24730260
[TBL] [Abstract][Full Text] [Related]
9. A MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancer.
Deng L; Ke X; He Z; Yang D; Gong H; Zhang Y; Jing X; Yao J; Chen J
Int J Nanomedicine; 2012; 7():5053-65. PubMed ID: 23028227
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Characterization, and Application of Core-Shell Co0.16Fe2.84O4@NaYF4(Yb, Er) and Fe3O4@NaYF4(Yb, Tm) Nanoparticle as Trimodal (MRI, PET/SPECT, and Optical) Imaging Agents.
Cui X; Mathe D; Kovács N; Horváth I; Jauregui-Osoro M; Torres Martin de Rosales R; Mullen GE; Wong W; Yan Y; Krüger D; Khlobystov AN; Gimenez-Lopez M; Semjeni M; Szigeti K; Veres DS; Lu H; Hernández I; Gillin WP; Protti A; Petik KK; Green MA; Blower PJ
Bioconjug Chem; 2016 Feb; 27(2):319-28. PubMed ID: 26172432
[TBL] [Abstract][Full Text] [Related]
11. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity.
Tong S; Hou S; Zheng Z; Zhou J; Bao G
Nano Lett; 2010 Nov; 10(11):4607-13. PubMed ID: 20939602
[TBL] [Abstract][Full Text] [Related]
12. Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes.
Frascione D; Diwoky C; Almer G; Opriessnig P; Vonach C; Gradauer K; Leitinger G; Mangge H; Stollberger R; Prassl R
Int J Nanomedicine; 2012; 7():2349-59. PubMed ID: 22661890
[TBL] [Abstract][Full Text] [Related]
13. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
[TBL] [Abstract][Full Text] [Related]
14. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
[TBL] [Abstract][Full Text] [Related]
15. Relaxation behavior study of ultrasmall superparamagnetic iron oxide nanoparticles at ultralow and ultrahigh magnetic fields.
Wang W; Dong H; Pacheco V; Willbold D; Zhang Y; Offenhaeusser A; Hartmann R; Weirich TE; Ma P; Krause HJ; Gu Z
J Phys Chem B; 2011 Dec; 115(49):14789-93. PubMed ID: 21972868
[TBL] [Abstract][Full Text] [Related]
16. Peptide-Decorated Ultrasmall Superparamagnetic Nanoparticles as Active Targeting MRI Contrast Agents for Ovarian Tumors.
Yin J; Yao D; Yin G; Huang Z; Pu X
ACS Appl Mater Interfaces; 2019 Nov; 11(44):41038-41050. PubMed ID: 31618000
[TBL] [Abstract][Full Text] [Related]
17. Quantitative effects of cell internalization of two types of ultrasmall superparamagnetic iron oxide nanoparticles at 4.7 T and 7 T.
Brisset JC; Desestret V; Marcellino S; Devillard E; Chauveau F; Lagarde F; Nataf S; Nighoghossian N; Berthezene Y; Wiart M
Eur Radiol; 2010 Feb; 20(2):275-85. PubMed ID: 19705124
[TBL] [Abstract][Full Text] [Related]
18. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
[TBL] [Abstract][Full Text] [Related]
19. Ultrasmall superparamagnetic nanoparticles targeting E-selectin: synthesis and effects in mice in vitro and in vivo.
Liu L; Liu L; Li Y; Huang X; Gu D; Wei B; Su D; Jin G
Int J Nanomedicine; 2019; 14():4517-4528. PubMed ID: 31354271
[No Abstract] [Full Text] [Related]
20. 99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes.
Madru R; Kjellman P; Olsson F; Wingårdh K; Ingvar C; Ståhlberg F; Olsrud J; Lätt J; Fredriksson S; Knutsson L; Strand SE
J Nucl Med; 2012 Mar; 53(3):459-63. PubMed ID: 22323777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
